2018
DOI: 10.3390/nano8040201
|View full text |Cite
|
Sign up to set email alerts
|

Biocompatibility of Gd-Loaded Chitosan-Hyaluronic Acid Nanogels as Contrast Agents for Magnetic Resonance Cancer Imaging

Abstract: Although the research on nanogels incorporating Gd chelates for theranostic applications has grown exponentially in recent years, knowledge about their biocompatibility is limited. We compared the biocompatibility of Gd-loaded hyaluronic acid-chitosan-based nanogels (GdCA⊂CS-TPP/HA) with two chitosan concentrations (2.5 and 1.5 mg·mL−1 respectively) using SVEC4-10 murine lymph node endothelial cells. The sulforhodamine B method and released lactate dehydrogenase (LDH) activity were used as cell viability tests… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 80 publications
(102 reference statements)
1
12
0
Order By: Relevance
“…Commercial CAs show relaxivity values between 4 and 5 mM −1 s −1 at 20 MHz and 310 K. In the past few years, many efforts have been made to improve CAs performance in terms of relaxivity values, biodistribution profile, and clearance time. One of the proposed strategies is the employment of macromolecular (polymers [9,10] and dendrimers [11,12]) or supramolecular (micelles [13][14][15], liposomes [16,17], nanogels [18,19], nanotubes [20,21], and fibers [22,23]) nanostructures for the delivery of Gd(III)-CAs. Due to their size and to their slow reorientation time, each gadolinium complex embedded in the nanostructure has a relaxivity value 2-5-fold higher in respect of the values associated to classical low molecular weight Gd-complexes.…”
Section: Introductionmentioning
confidence: 99%
“…Commercial CAs show relaxivity values between 4 and 5 mM −1 s −1 at 20 MHz and 310 K. In the past few years, many efforts have been made to improve CAs performance in terms of relaxivity values, biodistribution profile, and clearance time. One of the proposed strategies is the employment of macromolecular (polymers [9,10] and dendrimers [11,12]) or supramolecular (micelles [13][14][15], liposomes [16,17], nanogels [18,19], nanotubes [20,21], and fibers [22,23]) nanostructures for the delivery of Gd(III)-CAs. Due to their size and to their slow reorientation time, each gadolinium complex embedded in the nanostructure has a relaxivity value 2-5-fold higher in respect of the values associated to classical low molecular weight Gd-complexes.…”
Section: Introductionmentioning
confidence: 99%
“…The average particle size, polydispersity index (PDI), and zeta potential (ZP) were measured. Triplicate determinations for each formulation were carried out and the mean±SD was deduced 18…”
Section: Methodsmentioning
confidence: 99%
“…Very recently, Dinischiotu et al, in collaboration with Chuburu's group, thoroughly investigated the biocompatibility of these CH/TPP/HA nanogels prepared at two different concentrations of CH (2.5 and 1.5 mg mL À1 ) and loaded with Gd-DOTP or Gd-DOTA complexes. 80 Quantication of the gadolinium ions highlighted the better loading capability of the formulations containing 2.5 mg mL À1 of CH. The CH concentration, type of acid or gadolinium contrast agent did not affect the cell survival proles and the LDH release in SVEC4-10 murine lymph node endothelial cells.…”
Section: Gd Complex Encapsulated In Nanogelsmentioning
confidence: 96%